SCHEMBL5147708

SCHEMBL5147708

COCCC(=O)Nc1cnc2cc(Br)ccc2c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
KDR P35968 3/20 0.40
EGFR P00533 2/20 0.40
MAP4K4 O95819 2/20 0.38
TSHR P16473 2/20 0.38
HTT P42858 1/20 0.38
GSK3B P49841 1/20 0.38
MALT1 Q9UDY8 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
MAPK8 P45983 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5146626 0.88 GSK3B (0.49) ALDH1A1KDRTSHRHTTGSK3B
SCHEMBL5146641 0.81 ALDH1A1 (0.49) ALDH1A1TSHRHTTPOLBHPGD
SCHEMBL2815220 0.81 HPGD (0.43) ALDH1A1EGFRTSHRHTTHPGD
SCHEMBL23037527 0.80 KDM4E (0.42) KDREGFRPOLBKMT2A
SCHEMBL23037489 0.77 EGFR (0.51) KDREGFRHTTHDAC3HDAC1
SCHEMBL5767044 0.76 NPC1 (0.50) ALDH1A1KDRTSHRMAPT
SCHEMBL6920844 0.74 POLB (0.45) ALDH1A1POLBHPGDMEN1CYP1A2
SCHEMBL5763717 0.73 NPC1 (0.49) ALDH1A1GSK3BPOLBCYP1A2
SCHEMBL5766643 0.73 POLB (0.56) ALDH1A1TSHRHTTGSK3BPOLB
SCHEMBL2040755 0.73 POLB (0.44) ALDH1A1POLBHPGDMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259907-A1 ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES 3M INNOVATIVE PROPERTIES COMPANY 2007-11-08 US disclosed
WO-2006093514-A2 ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259907-A1 ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES IL2, TSLP, IFNG ALDH1A1 521/4885KDR 1601/4885EGFR 943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.